208 results
Page 6 of 11
8-K
EX-99.1
o1i 2bne6r
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
wll5csa5s571vh0p
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
ebwaxmornxd
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
iguh0aviya kytve4k
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
z4j1v2q
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
wlk92g6fd
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
skgagd tubrvk6q5knf
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
tz84hfrietocki3
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
6qoxu1h u2gulslfhw8l
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
iff g052i
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
hz4lma3marod7fsmr
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
xvram8 1rp26z7nhqvs
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
zj7w3r9du1qx11rponvv
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
10p4x
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
4d3ct hbe3s
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm